Showing results (351-360 of 3,148) with videos related to

Sort By:
Pageof 315
Neuro-Oncology|February 28, 2013
Inhibition of prolyl 4-hydroxylase, beta polypeptide (P4HB) attenuates temozolomide resistance in malignant glioma via the endoplasmic reticulum stress response (ERSR) pathwaysStella Sun, Derek Lee, Amy S W Ho, et al.
Neuro-Oncology|February 28, 2013
The frequency, longitudinal course, clinical associations, and causes of emotional distress during primary treatment of cerebral gliomaAlasdair Grant Rooney, Shanne McNamara, Mairi Mackinnon, et al.
Neuro-Oncology|February 28, 2013
Identifying the mesenchymal molecular subtype of glioblastoma using quantitative volumetric analysis of anatomic magnetic resonance imagesKourosh M Naeini, Whitney B Pope, Timothy F Cloughesy, et al.
Neuro-Oncology|April 19, 2013
Molecular interactions of ErbB1 (EGFR) and integrin-β1 in astrocytoma frozen sections predict clinical outcome and correlate with Akt-mediated in vitro radioresistanceMiklós Petrás, Tamás Lajtos, Elza Friedländer, et al.
Neuro-Oncology|June 18, 2013
Quantitative characterization of the imaging limits of diffuse low-grade oligodendrogliomasChloé Gerin, Johan Pallud, Christophe Deroulers, et al.
Neuro-Oncology|July 17, 2013
Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor studyJacques Grill, Birgit Geoerger, Lyle Gesner, et al.
Neuro-Oncology|July 24, 2013
TGM2 inhibition attenuates ID1 expression in CD44-high glioma-initiating cellsJun Fu, Qun-ying Yang, Ke Sai, et al.
Neuro-Oncology|August 13, 2013
Cells with intense EGFR staining and a high nuclear to cytoplasmic ratio are specific for infiltrative glioma: a useful marker in neuropathological practiceFanny Burel-Vandenbos, Laurent Turchi, Maxime Benchetrit, et al.
Neuro-Oncology|August 13, 2013
The cost-effectiveness of temozolomide in the adjuvant treatment of newly diagnosed glioblastoma in the United StatesAndrew Messali, Joel W Hay, Reginald Villacorta
Neuro-Oncology|August 6, 2013
Enzastaurin before and concomitant with radiation therapy, followed by enzastaurin maintenance therapy, in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylationWolfgang Wick, Joachim P Steinbach, Michael Platten, et al.
Pageof 315